Literature DB >> 12610094

Burkitt's lymphoma: new insights into molecular pathogenesis.

C Bellan1, S Lazzi, G De Falco, A Nyongo, A Giordano, L Leoncini.   

Abstract

The World Health Organisation classification reports three subcategories of Burkitt's lymphoma (BL)--endemic, non-endemic, and immunodeficiency associated--proposed to reflect the major clinical and genetic subtypes of this disease. These different types of BL have been reviewed and studied by immunohistochemistry and molecular methods. The results point out the heterogeneity of BL and suggest that AIDS related BL may have a different pathogenesis from that of classic BL.

Entities:  

Mesh：

Year:  2003        PMID： 12610094      PMCID： PMC1769902          DOI： 10.1136/jcp.56.3.188

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


  41 in total

1.  Human Kaposi's sarcoma cell-mediated tumorigenesis in human immunodeficiency type 1 tat-expressing transgenic mice.

Authors:  O Prakash; Z Y Tang; Y E He; M S Ali; R Coleman; J Gill; G Farr; F Samaniego
Journal:  J Natl Cancer Inst       Date:  2000-05-03       Impact factor: 13.506

2.  VH gene analysis in sporadic Burkitt's lymphoma: somatic mutation and intraclonal diversity with special reference to the tumor cells involving germinal center.

Authors:  Kouichi Isobe; Jun-Ichi Tamaru; Shigeo Nakamura; Kenichi Harigaya; Atsuo Mikata; Hisao Ito
Journal:  Leuk Lymphoma       Date:  2002-01

3.  Regression and clonally distinct recurrence of human immunodeficiency virus related Burkitt-like lymphoma during antiretroviral therapy.

Authors:  C Sarkodee-Adoo; L Pittarelli; E Jaffe; L Sorbara; M Raffeld; X Yao; R Haddad; T Heller
Journal:  Leuk Lymphoma       Date:  2001 Sep-Oct

4.  Retinoblastoma-related p107 and pRb2/p130 proteins in malignant lymphomas: distinct mechanisms of cell growth control.

Authors:  L Leoncini; C Bellan; A Cossu; P P Claudio; S Lazzi; C Cinti; G Cevenini; T Megha; L Laurini; P Luzi; G F Orcioni; M Piccioli; S Pileri; C Giardino; P Tosi; A Giordano
Journal:  Clin Cancer Res       Date:  1999-12       Impact factor: 12.531

5.  Genetic alterations of the retinoblastoma-related gene RB2/p130 identify different pathogenetic mechanisms in and among Burkitt's lymphoma subtypes.

Authors:  C Cinti; L Leoncini; A Nyongo; F Ferrari; S Lazzi; C Bellan; R Vatti; A Zamparelli; G Cevenini; G M Tosi; P P Claudio; N M Maraldi; P Tosi; A Giordano
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

6.  Non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy.

Authors:  O Kirk; C Pedersen; A Cozzi-Lepri; F Antunes; V Miller; J M Gatell; C Katlama; A Lazzarin; P Skinhøj; S E Barton
Journal:  Blood       Date:  2001-12-01       Impact factor: 22.113

7.  Expression of a human polyomavirus oncoprotein and tumour suppressor proteins in medulloblastomas.

Authors:  L Del Valle; J Baehring; C Lorenzana; A Giordano; K Khalili; S Croul
Journal:  Mol Pathol       Date:  2001-10

8.  Genetic alterations disrupting the nuclear localization of the retinoblastoma-related gene RB2/p130 in human tumor cell lines and primary tumors.

Authors:  C Cinti; P P Claudio; C M Howard; L M Neri; Y Fu; L Leoncini; G M Tosi; N M Maraldi; A Giordano
Journal:  Cancer Res       Date:  2000-01-15       Impact factor: 12.701

9.  The Burkitt-like lymphomas: a Southwest Oncology Group study delineating phenotypic, genotypic, and clinical features.

Authors:  R M Braziel; D A Arber; M L Slovak; M L Gulley; C Spier; C Kjeldsberg; J Unger; T P Miller; R Tubbs; C Leith; R I Fisher; T M Grogan
Journal:  Blood       Date:  2001-06-15       Impact factor: 22.113

10.  Changing incidence and survival in patients with aids-related non-Hodgkin's lymphomas in the era of highly active antiretroviral therapy (HAART).

Authors:  K U Chow; P S Mitrou; K Geduldig; E B Helm; D Hoelzer; H R Brodt
Journal:  Leuk Lymphoma       Date:  2001-03
View more
  22 in total

Review 1.  Emerging non-transplant-based strategies in treating pediatric non-Hodgkin's lymphoma.

Authors:  Lia Gore; Tanya M Trippett
Journal:  Curr Hematol Malig Rep       Date:  2010-10       Impact factor: 3.952

2.  Expression of JL1 in Burkitt lymphoma is associated with improved overall survival.

Authors:  Ilseon Hwang; Heounjeong Go; Yoon Kyung Jeon; Young Hyeh Ko; Dok Hyun Yoon; Cheolwon Suh; Joo Ryung Huh; Hyangsin Lee; Minchan Gil; Chan-Sik Park
Journal:  Virchows Arch       Date:  2011-08-04       Impact factor: 4.064

3.  Azidothymidine inhibits NF-kappaB and induces Epstein-Barr virus gene expression in Burkitt lymphoma.

Authors:  Motoki Kurokawa; Subrata K Ghosh; Juan Carlos Ramos; Abdul M Mian; Ngoc L Toomey; Lisa Cabral; Denise Whitby; Glen N Barber; Dirk P Dittmer; William J Harrington
Journal:  Blood       Date:  2005-03-24       Impact factor: 22.113

Review 4.  Non-Hodgkin's lymphoma in children and adolescents.

Authors:  Neerav N Shukla; Tanya M Trippett
Journal:  Curr Oncol Rep       Date:  2006-09       Impact factor: 5.075

5.  Protein kinase C-beta inhibition induces apoptosis and inhibits cell cycle progression in acquired immunodeficiency syndrome-related non-hodgkin lymphoma cells.

Authors:  Nakhle S Saba; Laura S Levy
Journal:  J Investig Med       Date:  2012-01       Impact factor: 2.895

Review 6.  Molecular diagnosis in lymphoma.

Authors:  Adam Bagg
Journal:  Curr Oncol Rep       Date:  2004-09       Impact factor: 5.075

7.  Critical role of EBNA1-specific CD4+ T cells in the control of mouse Burkitt lymphoma in vivo.

Authors:  Tihui Fu; Kui Shin Voo; Rong-Fu Wang
Journal:  J Clin Invest       Date:  2004-08       Impact factor: 14.808

8.  Identification of mitochondrial genome concatemers in AIDS-associated lymphomas and lymphoid cell lines.

Authors:  Felipe Bedoya; Maria M Medveczky; Troy C Lund; Andras Perl; Joseph Horvath; Stephen D Jett; Peter G Medveczky
Journal:  Leuk Res       Date:  2009-04-11       Impact factor: 3.156

Review 9.  HIV infection and lymphoma.

Authors:  K L Grogg; R F Miller; A Dogan
Journal:  J Clin Pathol       Date:  2007-12       Impact factor: 3.411

Review 10.  Epstein-Barr virus and Burkitt lymphoma.

Authors:  G Brady; G J MacArthur; P J Farrell
Journal:  J Clin Pathol       Date:  2007-12       Impact factor: 3.411
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.